MMP Capital closed a landmark year defined by record performance, national expansion and rising momentum across its national platform. The company reported $437 million in originations in 2025, the highest annual total in its history.
“Reaching $437 million in originations is a defining achievement for MMP Capital. Most of the growth was organic, since many of the investments we have made in 2025 have not come close to their potential. It speaks to the strength of both our reputation in healthcare finance, as well as the relationships that our customers have built with our team,” John-Paul Smolenski, CEO of MMP Capital, said. “Our customers appreciate that they finally found a lending company that they can trust, and who can consistently secure their capital. This growth was earned through the standards of our culture which emphasize consistency, discipline and a clear focus on precise execution.”
In 2025, MMP Capital opened two new facilities in New Hampshire and Massachusetts, opening up new industries to their business model.
“The facilities we opened in New Hampshire and Massachusetts in 2025 have already expanded our reach and operating capacity, and it is energizing to see those investments translate directly into growth,” Smolenski said.
MMP Capital confirmed plans to expand its Long Island facility in February 2026, aligning with sustained origination growth and increasing deal flow. The expansion represents continued investment in infrastructure, systems and personnel to support the next phase of growth.
“We are moving into a larger state of the art office in Melville, Long Island in February 2026 to provide the infrastructure to support the rising volume and opportunity,” Smolenski said. “We are investing in space, technology and people to serve our clients at a higher level as activity continues to accelerate.”
